Biotechnology, Research, and Healthcare by ACADIA Pharmaceuticals
Acadia Pharmaceuticals stock surges 6.75% as CHMP backs Rett syndrome drug, Acadia Pharmaceuticals announces
Acadia Pharmaceuticals announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion recommending marketing authorization for its treatment for the ...
Acadia Pharmaceuticals stock rallies after EU panel supports Rett syndrome medicine approval
Acadia Pharmaceuticals announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion recommending marketing authorization for its treatment for neurobehavioral ...
Acadia Pharmaceuticals stock climbs 3.36% as Acadia Pharmaceuticals gears up for RettSyndrome meeting
Acadia Pharmaceuticals will present its latest data in Rett Syndrome at the upcoming RettSyndrome Scientific Meeting.Acadia Pharmaceuticals stated it will join clinicians, researchers, and Rett ...
Acadia Pharmaceuticals stock holds near $21.56 as company supports Alzheimer awareness month
Acadia Pharmaceuticals announced June as Alzheimer’s and Brain Awareness Month, an initiative founded by the Alzheimer’s Association to raise awareness about Alzheimer’s disease.The company ...
Acadia Pharmaceuticals stock trades down with sideways action after recent recovery
Acadia Pharmaceuticals marked June as Alzheimer's and Brain Awareness Month, an initiative founded by the Alzheimer's Association to increase awareness of Alzheimer's disease.The company stated ...
Acadia Pharmaceuticals stock edges higher to $21.72 as AcadiaPharma promotes Parkinsons findings in D.C.
Acadia Pharmaceuticals announced it is traveling to Washington D.C. this week for the PMDAlliance #ATMRD2026 Congress.The company will share its latest findings in Parkinson's Disease psychosis ...
Acadia Pharmaceuticals stock edges higher to $21.72 as AcadiaPharma promotes Parkinsons study event
Acadia Pharmaceuticals is traveling to Washington D.C. this week for the PMD Alliance #ATMRD2026 Congress.The company will share its latest findings in Parkinson's Disease psychosis and Essential ...
Acadia Pharmaceuticals stock drops 3.35% as company gears up for post-acute care conference
Acadia Pharmaceuticals announced it is attending the PALTmed Annual Conference in Anaheim this week. The company plans to share its recent learnings in Parkinson's Disease at the event.Acadia ...
Acadia Pharmaceuticals stock price forecast: overbought conditions persist as ACAD closes near key resistance
Acadia Pharmaceuticals said it will attend the PALTmed Annual Conference in Anaheim this week.The company will share its recent learnings in Parkinson’s disease and explore insights shaping ...
ACADIA Pharmaceuticals invites engagement at major pediatric event
ACADIA Pharmaceuticals is participating in the 47th National Conference on Pediatric Health Care this week, inviting attendees to visit Booth 408 and connect with its team. The company is ...
Acadia Pharmaceuticals annual revenue surpasses 1 billion dollars at Nasdaq bell ceremony
Acadia Pharmaceuticals has exceeded 1 billion dollars in annual revenue for the first time, marking a significant milestone celebrated with the ringing of the Opening Bell at the Nasdaq Exchange. ...
ACADIA Pharmaceuticals confirms role at Stifel 2026 Virtual CNS Forum
ACADIA Pharmaceuticals announced its participation in the upcoming Stifel 2026 Virtual CNS Forum. The company is set to engage with industry peers and stakeholders during the event, highlighting ...
ACADIA Pharmaceuticals unveils new Rett Syndrome research at Baltimore genetics meeting
ACADIA Pharmaceuticals has announced the presentation of its latest research developments on Rett Syndrome at the Annual Clinical Genetics Meeting taking place this week in Baltimore. Attendees ...
ACADIA Pharmaceuticals to exhibit at ACMG event in Baltimore
ACADIA Pharmaceuticals announced it will take part in the Annual Clinical Genetics Meeting hosted by the American College of Medical Genetics and Genomics in Baltimore, Maryland this week. The ...
ACADIA Pharmaceuticals reports Q3 2025 earnings update
ACADIA Pharmaceuticals announced its third quarter 2025 earnings results today. The company provided a comprehensive financial summary and key updates that are now available for stakeholders and ...
